Offered by: Nemours
Locations: Delaware Valley, Jacksonville, FL, Orlando, FL, Pensacola, FL
What is the trial about?
To find out if adding a third drug (doxorubicin) plus giving radiation therapy, will improve the chance for cure for participants with Stage I focal or diffuse anaplastic Wilms tumor.
Who can participate?
Patients with anaplastic Wilms tumor, malignant rhabdoid tumor, clear cell sarcoma of the kidney, and renal cell carcinoma.
What is involved?
Length of study is 25 weeks. Standard cancer care treatment.
Contact Nemours Clinical Trials
Trial Name: Treatment of High Risk Renal Tumors